Table 3.

Association of day 100 CCL15 levels with subsequent cGVHD (n = 792)

Prognostic markerArea ROCP
CCL15 0.56 .03 
Clinical factors* 0.61 .10† 
CCL15 + steroid use + female to male sex 0.62 .001 
Prognostic markerArea ROCP
CCL15 0.56 .03 
Clinical factors* 0.61 .10† 
CCL15 + steroid use + female to male sex 0.62 .001 
*

Female to male sex, donor relation/match, stem cell source, age, conditioning, steroid use.

†

Only steroid use (P = .02) and female to male sex (P = .04) are statistically significant.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal